Mode
Text Size
Log in / Sign up

Inflammatory diseases

7 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for inflammatory diseases

4 trials tracked for inflammatory diseases.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 1 2 Other / NA 2
  1. Phase 1 Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants Completed
  2. Phase 1 Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function Completed
  3. N/A Translational Development of Photon-counting CT Imaging Completed
  4. N/A PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about inflammatory diseases

Does targeting ISG15 help with skin inflammatory diseases?

Targeting the ISG15 pathway shows potential for treating skin inflammatory diseases because ISG15 can act as a cytokine that worsens inflammation, but current research is mostly theoretical.

Full answer →
Can marine sponge compounds treat infections and inflammatory diseases?

Marine sponge compounds show promise for treating infections and inflammatory diseases, with specific examples like manzamines for malaria and diketopiperazines for sepsis.

Full answer →